Physician profile
David Jay Weber
NPI 1902987829
$338,940.79
in general payments reported to CMS, 2019-2025
14 companies · $99K in 2025
The $99K reported for 2025 was more than what 98% of Pediatric Infectious Diseases providers received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $11K · 2021: $39K · 2022: $69K · 2023: $31K · 2024: $48K · 2025: $99K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $79K · Consulting Fee: $65K · Travel and Lodging: $25K · Honoraria: $7,600 · Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $78,512.00 |
| Consulting Fee | $65,430.00 |
| Travel and Lodging | $25,389.82 |
| Honoraria | $7,600.00 |
| Food and Beverage | $1,545.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $139,256.19 | 2019-2025 | |
| Davol INC. | $37,962.25 | 2022-2025 | |
| Pfizer International LLC | $36,803.73 | 2021-2023 | |
| Germitec North America INC | $32,000.00 | 2025 | Germitec Chronos |
| Merck Sharp & Dohme LLC | $25,445.49 | 2019-2024 | |
| Dynavax Technologies Corporation | $20,666.52 | 2019-2021 | |
| Glaxosmithkline, LLC. | $20,531.69 | 2022-2025 | |
| Becton, Dickinson and Company | $6,290.00 | 2023-2024 | |
| Seqirus USA INC | $6,000.00 | 2021 | |
| Modernatx, INC. | $4,875.00 | 2024-2025 | |
| Tetraphase Pharmaceuticals, INC. | $4,471.27 | 2019 | |
| Sanofi Pasteur INC. | $3,304.00 | 2021 | |
| Shionogi INC | $1,295.26 | 2019 | |
| Medline Industries Lp | $39.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.